Gates Foundation Owned Gilead Sciences Stands To Make $Billions From CoronaVirus Drug Remdesivir
Gilead could be sitting on close to $20 billion in untapped stock market value, provided it has success with a potential new Coronavirus Vaccine.
Sauce: https://finance.yahoo.com/news/coronavirus-vaccine-could-add-billions-in-value-to-gilead-161233464.html?guccounter=1
In Hong Kong, health officials will start clinical trials with a still-unproven antiviral drug Remdesivir (Remdesivir is an Ebola drug) to treat the new Coronavirus.
“The cost as will be around $1,000 for a course and Governments will pay the Pharmaceutical company of course,” he notes.
The company behind this is the Gates Foundation owned Gilead Sciences.
“Imagine just 10 million doses to start with globally. This is $10 billion alone. Plus look at what their stock prices will do.
Sauce: https://www.biopharmadive.com/news/coronavirus-remdesivir-gilead-antiviral-drug-covid-19/573261/